Cite

HARVARD Citation

    Jensen, C. et al. (n.d.). Altered type III collagen turnover measured in pre-treatment serum predicts outcome in metastatic melanoma patients treated with Ipilimumab. European journal of cancer. pp. S7-. [Online]. 
  
Back to record